M. Galeazzi
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 22
- Rheumatoid Arthritis Research and Therapies 13
- Immunology top 10%
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 4
- Nephrology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 15
-
- Chronic Lymphocytic Leukemia Research 9
-
- Lymphoma Diagnosis and Treatment 8
- Systemic Sclerosis and Related Diseases 6
-
- Inflammasome and immune disorders 6
M. Galeazzi
63 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 89
- Complementary and Manual Therapy 86
- Rheumatology 551
- Immunology 344
- Hematology 157
- Nephrology 74
Countries citing papers authored by M. Galeazzi
This map shows the geographic impact of M. Galeazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Galeazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Galeazzi more than expected).
Fields of papers citing papers by M. Galeazzi
This network shows the impact of papers produced by M. Galeazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Galeazzi. The network helps show where M. Galeazzi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Galeazzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 31 | |
| 2 | 2017 | 36 | |
| 3 | 2015 | 6 | |
| 4 | 2014 | 71 | |
| 5 | 2014 | 14 | |
| 6 | 2014 | 1 | |
| 7 | A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate. | 2014 | 27 |
| 8 | 2013 | 20 | |
| 9 | 2013 | 14 | |
| 10 | 2012 | 3 | |
| 11 | 2012 | 9 | |
| 12 | 2012 | 1 | |
| 13 | 2011 | 3 | |
| 14 | 2010 | 30 | |
| 15 | 2009 | 53 | |
| 16 | 2009 | 17 | |
| 17 | 2008 | 26 | |
| 18 | 2006 | 20 | |
| 19 | 2006 | 47 | |
| 20 | 2003 | 60 |
About M. Galeazzi
M. Galeazzi is a scholar working on Rheumatology, Genetics and Hematology, having authored 66 papers that have together received 1.2k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (22 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Rheumatoid Arthritis Research and Therapies (13 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Inflammasome and immune disorders (6 papers), Systemic Sclerosis and Related Diseases (6 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). The work is most often cited by research in Complementary and Manual Therapy (86 citations), Rheumatology (551 citations) and Immunology (344 citations). M. Galeazzi has collaborated with scholars based in Italy, France and Germany. Frequent co-authors include Gian Domenico Sebastiani, Antonella Fioravanti, Francesca Bellisai, Sara Cheleschi, Luca Cantarini, Gabriella Morozzi, Roberto Marcolongo, Sara Tenti, Orso Maria Lucherini and Chiara Giannitti. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical Neurophysiology and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.